FDA Inspection 1147467 — Jim Bootsma Jr.

Jim Bootsma Jr. — FEI 1000135238

The FDA completed an inspection of Jim Bootsma Jr. on July 30, 2021 in Lakeview, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 30, 2021
Fiscal Year
2021
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Lakeview, CA (United States)

Citations

IDCFRDescription
1442FDCA 402(a)(4)Records review prior to shipment for slaughter
4185FDCA 402(a)(4)Record keeping
429821 CFR 530.11(a)Prescribed directions - not followed
7001FDCA 402(a)(4)Drug inventory (control of drugs on premises)